These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34903214)

  • 1. Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis.
    Kendall EA; Hussain H; Kunkel A; Kubiak RW; Trajman A; Menzies R; Drain PK
    BMC Med; 2021 Dec; 19(1):315. PubMed ID: 34903214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
    PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of tuberculosis disease in individuals diagnosed with tuberculosis infection after screening: A population-based cohort study in South Korea.
    Lee J; Kim D; Hwang J; Kwon JW
    Int J Infect Dis; 2024 Apr; 141():106961. PubMed ID: 38340783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting.
    Kay AW; Sandoval M; Mtetwa G; Mkhabela M; Ndlovu B; Devezin T; Sikhondze W; Vambe D; Sibanda J; Dube GS; Stevens RH; Lukhele B; Mandalakas AM
    Clin Infect Dis; 2022 May; 74(9):1631-1638. PubMed ID: 34302733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
    Suryavanshi N; Murrill M; Gupta A; Hughes M; Hesseling A; Kim S; Naini L; Jones L; Smith B; Gupte N; Dawson R; Mave V; Meshram S; Mendoza-Ticona A; Sanchez J; Kumarasamy N; Comins K; Conradie F; Shenje J; Nerette Fontain S; Garcia-Prats A; Asmelash A; Nedsuwan S; Mohapi L; Lalloo U; Cristina Garcia Ferreira A; Okeyo E; Swindells S; Churchyard G; Shah NS
    Clin Infect Dis; 2020 Jan; 70(3):436-445. PubMed ID: 30919881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.
    Dorjee K; Topgyal S; Tsewang T; Tsundue T; Namdon T; Bonomo E; Kensler C; Lhadon D; Choetso T; Nangsel T; Dolkar T; Tsekyi T; Dorjee C; Phunkyi D; Sadutshang TD; Paster Z; Chaisson RE
    PLoS Med; 2021 Jan; 18(1):e1003502. PubMed ID: 33465063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis Preventive Treatment.
    Tayal A; Kabra SK
    Indian J Pediatr; 2024 Aug; 91(8):823-829. PubMed ID: 38095783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates.
    Kasaie P; Pennington J; Gupta A; Dowdy DW; Kendall EA
    Clin Infect Dis; 2024 Jan; 78(1):133-143. PubMed ID: 37724763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.
    Krishnan S; Wu X; Kim S; McIntire K; Naini L; Hughes MD; Dawson R; Mave V; Gaikwad S; Sanchez J; Mendoza-Ticona A; Gonzales P; Comins K; Shenje J; Fontain SN; Omozoarhe A; Mohapi L; Lalloo UG; Garcia Ferreira AC; Mugah C; Harrington M; Shah NS; Hesseling AC; Churchyard G; Swindells S; Gupta A;
    Clin Infect Dis; 2023 Sep; 77(6):892-900. PubMed ID: 37227925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.
    Demers AM; Kim S; McCallum S; Eisenach K; Hughes M; Naini L; Mendoza-Ticona A; Pradhan N; Narunsky K; Poongulali S; Badal-Faesen S; Upton C; Smith E; Shah NS; Churchyard G; Gupta A; Hesseling A; Swindells S;
    BMC Infect Dis; 2021 Feb; 21(1):205. PubMed ID: 33627075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China.
    Chen H; Zhang H; Cheng J; Sun D; Wang Q; Wu C; Liu Y; Xia Y; Xu C; Zhang C
    Int J Infect Dis; 2024 Oct; 147():107196. PubMed ID: 39074738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expert consensus on tuberculosis preventive treatment for individuals at high risk of developing active diseases from latent tuberculosis infection in comprehensive medical facilities].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Oct; 47(10):933-945. PubMed ID: 39406540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of chemotherapy for tuberculosis in national tuberculosis programmes of low- and middle-income countries.
    Chiang CY; Lin CJ
    Indian J Tuberc; 2020 Dec; 67(4S):S16-S22. PubMed ID: 33308663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for tuberculosis screening and preventive treatment among pregnant and breastfeeding women living with HIV in PEPFAR-supported countries.
    Hirsch-Moverman Y; Hsu A; Abrams EJ; Killam WP; Moore B; Howard AA
    PLoS One; 2024; 19(4):e0296993. PubMed ID: 38625930
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.